Key Activities
Top-down education of health insurers, oncologists, and patients on clinical utility and economic value of CGP. Payer engagement; policy advocacy. Members: Exact Sciences, Foundation Medicine, Illumina, Labcorp, QIAGEN, Roche Diagnostics, Thermo Fisher Scientific, AstraZeneca, Lilly/Loxo, Blueprint Medicines, NeoGenomics, Tempus, Invitae.